Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study
Crossref DOI link: https://doi.org/10.1007/s11060-014-1680-2
Published Online: 2014-12-13
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chheda, Milan G.
Wen, Patrick Y.
Hochberg, Fred H.
Chi, Andrew S.
Drappatz, Jan
Eichler, April F.
Yang, Daniel
Beroukhim, Rameen
Norden, Andrew D.
Gerstner, Elizabeth R.
Betensky, Rebecca A.
Batchelor, Tracy T.
Text and Data Mining valid from 2014-12-13